热门资讯> 正文
CEL-SCI宣布定价570万美元
2025-07-12 03:04
- CEL-SCI (NYSE:CVM) announced on Friday the pricing of a best-efforts offering of 1,500,000 shares of its common stock.
- Each share of common stock is being sold at an offering price of $3.82 per share, priced at-the-market under NYSE American rules.
- Total gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be approximately $5.7 million.
- The offering is expected to close on July 14, 2025.
- The company intends to use the net proceeds from the offering to fund the continued development of Multikine, general corporate purposes, and working capital.
- CVM is -1.17% to $3.775.
- Source: Press Release
More on Cel-Sci
- Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit
- Biggest stock movers Thursday: Solar stocks, FNMA, and more
- Seeking Alpha’s Quant Rating on Cel-Sci
- Historical earnings data for Cel-Sci
- Financial information for Cel-Sci
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。